Cargando…
Expression Enhancement in Trastuzumab Therapeutic Monoclonal Antibody Production using Genomic Amplification with Methotrexate
BACKGROUND: Trastuzumab (Herceptin) is a humanized monoclonal antibody (mAb) which is used for specific treatment of metastatic breast cancer in patients with overexpression of HER2/neu receptor. In this study, we have attempted to develop a biosimilar version of trastuzumab mAb. METHODS: According...
Autores principales: | Akbarzadeh-Sharbaf, Soudabeh, Yakhchali, Bagher, Minuchehr, Zarrin, Shokrgozar, Mohammad Ali, Zeinali, Sirous |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Avicenna Research Institute
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3689561/ https://www.ncbi.nlm.nih.gov/pubmed/23799177 |
Ejemplares similares
-
In silico design, construction and cloning of Trastuzumab humanized monoclonal antibody: A possible biosimilar for Herceptin
por: Akbarzadeh-Sharbaf, Soudabeh, et al.
Publicado: (2012) -
The distribution of the therapeutic monoclonal antibodies cetuximab and trastuzumab within solid tumors
por: Lee, Carol M, et al.
Publicado: (2010) -
Hepatitis B Virus Genome Asymmetry in Hepatocellular Carcinoma
por: Shokrgozar, Zahra, et al.
Publicado: (2012) -
Identification of Natural Products as SENP2 Inhibitors for Targeted Therapy in Heart Failure
por: Taghvaei, Somayye, et al.
Publicado: (2022) -
The arrival of biosimilar monoclonal antibodies in oncology: clinical studies for trastuzumab biosimilars
por: Barbier, Liese, et al.
Publicado: (2019)